Stockreport

Johnson & Johnson Receives FDA Approval for TRUFILL n-BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF Approval builds on a trusted solution in neurovascular embolization for over 25 years. IRVINE, Calif. Dec. 18, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) – Tod [Read more]